+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization



Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization



Vaccine 11(6): 615-618



The cotton rat model has been used to evaluate the potential for immunogens to induce respiratory syncytial virus (RSV)-enhanced pulmonary histopathology. A recent study evaluated purified F protein in this model when animals were challenged intranasally with RSV 3 or 6 months after immunization. The authors concluded that the purified F protein was associated with the same level of histopathological changes as observed with the positive control, a formalin-inactivated RSV immunogen. Three pathologists have independently evaluated the lung sections from the animals of this study and the results are reported in this article. In contrast to the previously published data, we have found that F protein was associated with a substantially milder and qualitatively different response to that observed with the formalin-inactivated RSV vaccine. We concluded that the minimal histological changes observed and lack of clinical disease make it very difficult to assess the issue of enhanced pulmonary RSV disease with the cotton rat model.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046513675

Download citation: RISBibTeXText

PMID: 8322482

DOI: 10.1016/0264-410x(93)90304-g


Related references

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin inactivated respiratory syncytial virus rsv or purified f glycoprotein and challenged with rsv 3 6 months after immunization. Vaccine 8(5): 497-502, 1990

Detection of respiratory syncytial virus rsv infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin inactivated virus or purified rsv f and g glycoprotein subunit vaccine and challenged with rsv. Virus Research 16(2): 153-162, 1990

Subunit purified F protein vaccine from respiratory syncytial virus Lack of vaccine associated enhanced disease in cotton rats. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 347, 1993

Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice. Journal of Virology 84(18): 9632-9636, 2010

Enhanced pulmonary histopathology induced by respiratory syncytial virus challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 and IL-10. Journal of Virology 68(8): 5321-5325, 1994

Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25(27): 5034-5040, 2007

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. Journal of Infectious Diseases 155(6): 1198-1204, 1987

Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. Journal of Infectious Diseases 159(2): 255-264, 1989

Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences of the United States of America 83(6): 1906-1910, 1986

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. Vaccine 10(7): 475-484, 1992

Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. Journal of Infectious Diseases 163(3): 477-482, 1991

Mechanism by which intramuscular inoculation of formalin inactivated respiratory syncytial virus enhances pulmonary pathology in cotton rats subsequently infected with respiratory syncytial virus. Brown, F , R M Chanock And R A Lerner (Ed ) New Approaches to Immunization: Developing Vaccines Against Parasitic, Bacterial, And Viral Diseases; Conference on Vaccines 86, Cold Spring Harbor, N Y , Usa Xxi+418p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 261-266, 1986

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. Journal of General Virology 82(Pt 12): 2881-2888, 2001

Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 11(14): 1415-1423, 1993

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. Journal of Virology 66(12): 7444-7451, 1992